Yüklüyor......
Tumor pO(2) as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas
Glioblastomas are aggressive and highly vascularized primary brain tumors with a 5-year survival rate of less than 10%. Anti-angiogenic approaches are being investigated for potential therapeutic benefits for this fatal malignancy. However, lack of suitable markers that can be used to monitor therap...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3142470/ https://ncbi.nlm.nih.gov/pubmed/21445776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4419-7756-4_15 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|